TrianglePUBLICATIONS · 21562040
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2011 Aug 4
- First author
- Soverini S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Soverini S
- type
- Author
- name
- Hochhaus A
- type
- Author
- name
- Nicolini FE
- type
- Author
- name
- Gruber F
- type
- Author
- name
- Lange T
- type
- Author
- name
- Saglio G
- type
- Author
- name
- Pane F
- type
- Author
- name
- Müller MC
- type
- Author
- name
- Ernst T
- type
- Author
- name
- Rosti G
- type
- Author
- name
- Porkka K
- type
- Author
- name
- Baccarani M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Soverini S
- type
- Author
- name
- Hochhaus A
- type
- Author
- name
- Nicolini FE
- type
- Author
- name
- Gruber F
- type
- Author
- name
- Lange T
- type
- Author
- name
- Saglio G
- type
- Author
- name
- Pane F
- type
- Author
- name
- Müller MC
- type
- Author
- name
- Ernst T
- type
- Author
- name
- Rosti G
- type
- Author
- name
- Porkka K
- type
- Author
- name
- Baccarani M
- type
- Author
- bibliography ids
- nci-bib-1dc1283c98627dfc1b1d62ca
- book metadata
- content sha256
- 4d2ee011b74ca80c121ba8f514e188781cb2f1f52566439a9d71a562a41a8829
- document type
- citation
- dois
- 10.1182/blood-2010-12-326405
- electronic publication date
- display
- 2011 May 11
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21562040
- immutable id
- pubmed:21562040@4d2ee011b74ca80c121ba8f514e188781cb2f1f52566439a9d71a562a41a8829
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 5
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1208-15
- volume
- 118
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21562040
- provenance
- batch id
- a366a1bc8ed89d8d7ca5
- provider
- NCBI PubMed ESummary
- record sha256
- 90174b2908f09d8b6c2d00050f3c67f583354175f5e3427ed0348588388ca3a1
- response sha256
- c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
- retrieved at
- 2026-09-09T23:46:40.540025+00:00
- publication date
- display
- 2011 Aug 4
- precision
- day
- year
- 2011
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
Preserved source evidence · Not medical advice